Affiliation:
1. Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences,
Sari, Iran
2. Pharmacutical Science Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical
Sciences, Sari, Iran
Abstract
Background:
In recent years, it has been reported that long-term use of Non-Steroidal
Anti-Inflammatory Drugs (NSAIDs) may have protective effects against neurodegenerative diseases
by inhibiting the activity of cholinesterase enzymes. The exact biological mechanism of
these protective effects is not yet known. This study aims to assess the in vivo and in vitro effects
of aspirin and ibuprofen injection on the activity of acetylcholinesterase and butyrylcholinesterase.
Materials and Methods:
In this experimental study, 70 adult male mice (20-25 g) were divided
randomly into 7 groups (n= 10) including a control group that received normal saline and other
groups that received different dosages of aspirin and ibuprofen (100, 200, and 300 mg/kg) in the
form of intraperitoneal injection. Mice were anesthetized by ether, and blood samples were taken
from the heart. Ellman´s methods were used to measure cholinesterase, erythrocytes, and serum,
respectively.
objective:
This study aims to assess the in vivo and in vitro effects of aspirin and ibuprofen injection on the activity of acetylcholinesterase and butyrylcholinesterase.
Results:
The activity of cholinesterase enzymes in serum and erythrocytes decreased significantly
(P<0.0001) in treated groups with aspirin and ibuprofen compared to the control samples after
3 and 24 hours. However, these inhibitory effects were variable depending on the dose of the injected
drugs, and they were statistically significant at higher injection doses in vitro and in vivo
analysis.
Conclusion:
The result of this study showed that non-steroidal anti-inflammatory drugs can inhibit
the activity of the cholinesterase enzymes in both in vivo and in vitro conditions compared
to the control group.
Publisher
Bentham Science Publishers Ltd.